Page last updated: 2024-08-24

saterinone and Chronic Illness

saterinone has been researched along with Chronic Illness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baumann, G; Eichner, E; Iven, H; Kieback, AG; Ruckdeschel, W; Stolzenburg, K	1

Other Studies

1 other study(ies) available for saterinone and Chronic Illness

Article	Year
Pharmacokinetics and hemodynamic effects of the phosphodiesterase III inhibitor saterinone in patients with chronic heart failure. International journal of cardiology, 2003, Volume: 91, Issue:2-3 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Blood Platelets; Blood Pressure; Chronic Disease; Creatine Kinase; Creatinine; Cyclic Nucleotide Phosphodiesterases, Type 3; Diastole; Heart Atria; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Pyridones; Statistics as Topic; Stroke Volume; Systole; Time Factors; Treatment Outcome; Vascular Resistance	2003

Article

Year

Pharmacokinetics and hemodynamic effects of the phosphodiesterase III inhibitor saterinone in patients with chronic heart failure.

International journal of cardiology, 2003, Volume: 91, Issue:2-3

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Blood Platelets; Blood Pressure; Chronic Disease; Creatine Kinase; Creatinine; Cyclic Nucleotide Phosphodiesterases, Type 3; Diastole; Heart Atria; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Pyridones; Statistics as Topic; Stroke Volume; Systole; Time Factors; Treatment Outcome; Vascular Resistance

2003